|
Resolution: standard / high Figure 3.
Signaling substances in bone marrow interstitial fluid (BMIF) in leukemia. (A) Growth of normal bone marrow progenitor cells (CD34 cells) added BMIF from patients
with acute myeloid leukemia (AML) before and after induction chemotherapy. A marked
increase in colony numbers (*P < 0.05) was noted upon this initial treatment in 7 of 10 patients with AML entering
complete remission. BMIF from the remaining three AML patients that only entered partial
remission yielded similar colony numbers before and after induction chemotherapy.
Colony formation in the presence of normal BMIF is shown for comparison. (B) Tumor
necrosis factor (TNF)-α concentrations in plasma and BMIF before and after induction
chemotherapy in 7 of 10 patients with AML entering complete remission. This treatment
resulted in a substantial fall in TNF-α concentration (*P < 0.05) in the BMIF, but not in plasma. Normal plasma and BMIF values are shown for
comparison. Individual values are shown. Horizontal lines refer to means. Modified
from [78].
Wiig et al. Fibrogenesis & Tissue Repair 2010 3:12 doi:10.1186/1755-1536-3-12 |